Caregiver Expressed Emotion, Quality of Life and Medication Adherence among People Living with Schizophrenia in Nigeria

Babandi, Fawaz; UM, Usman; ZG, Habib; DS, Owolabi; MI, Gudaji; AA, Taura; CN, Aghukwa; AS, Baguda; AS, Salihu

doi:10.37871/jbres1489

Cited by 1 publication

(1 citation statement)

References 12 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The data was obtained from a study on caregiver expressed emotion, QoL and medication adherence among people living with schizophrenia, published elsewhere. [6] The following instruments were used: 1) Socio-demographic and Schizophrenia Clinical Variables Questionnaire Apart from the socio-demographics of the patients, the clinical section of this instrument was used to subjectively and objectively assess for the presence or absence of antipsychotics related side-effects among the respondents. Open Journal of Psychiatry 2) MINI International Neuropsychiatric Interview (MINI)-7.0 Scale MINI-7 corresponds to DSM-5 diagnosis and it has been used to confirm the lifetime diagnosis of schizophrenia among respondents.…”

Section: Methodsmentioning

confidence: 99%

A Comparison of Quality of Life, Medication Side-Effect and Adherence among Schizophrenia Patients on Conventional versus Atypical Antipsychotics

Babandi¹,

Usman²,

Habib³

et al. 2023

OJPsych

View full text Add to dashboard Cite

Quality of life (QoL) is becoming a widely accepted schizophrenia management outcome. But it is still not very clear if there are any significant differences between the conventional and atypical antipsychotics in terms of QoL improvement among people with schizophrenia (PWS). It is also imperative that antipsychotic drug-related factors, such as medication adherence and side-effect, which could directly or indirectly affect the QoL of PWS, are determined and compared among PWS on different classes of the drugs. Data were collected on Socio-demographic Characteristics, Quality of Life and Medication adherence using Socio-demographic and Schizophrenia Clinical Characteristics questionnaire, World Health Organization Quality of Life (WHOQoL)-Brief, and Morisky Medication Adherence Scale (MMAS) respectively from 250 respondents attending a tertiary health center's Psychiatric clinic in Kano, Nigeria. Although PWS on the two classes of antipsychotic drugs showed inequalities in different aspects and domains of QoL, as well as in the levels of adherence and side-effects, the differences were all insignificant. However, presence of drug side effects was significantly associated with lower health-related QoL in the conventional antipsychotics group (p = 0.001), and lower score in the physical domain of QoL in the atypical antipsychotics group (p = 0.044). Medication adherence was found to be associated with better scores in different domains of QoL in both groups of PWS. There are no significant differences in terms of QoL, medication side-effect and adherence among PWS on the two classes of antipsychotics. However, drug side-effects and adherence were significantly and respectively associated How to cite this paper: Babandi, F.

show abstract

Section: Methodsmentioning

confidence: 99%